Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
Clinical Neurophysiology Practice|February 22, 2021
Trigeminal nerve electrophysiological findings in hemifacial atrophy: A systematic literature review and retrospective chart reviewMichael P Skolka, Lisa A Marks, Lyell K Jones, et al.Acta Paediatrica (Oslo, Norway : 1992)|June 2, 2011
Predictors of death in under-five children with diarrhoea admitted to a critical care ward in an urban hospital in BangladeshMohammod J Chisti, Mark A C Pietroni, Jonathan H Smith, et al.Headache|July 26, 2019
CSF Pressure, Volume, and Post-Dural Puncture Headache: A Case-Control Study and Systematic ReviewJonathan H Smith, Brian Mac Grory, Richard J Butterfield, et al.Headache|June 20, 2023
Frequency of headache in emergency department patients with anaphylaxis: A cross-sectional studyYuedan Zhang, Jonathan H Smith, Aidan F Mullan, et al.Headache|August 28, 2024
Healthcare resource use and costs associated with the misdiagnosis of migraineJae Rok Kim, Tae Jin Park, Maria Agapova, et al.The Lancet. Neurology|December 3, 2014
Pain assessment in elderly adults with dementiaThomas Hadjistavropoulos, Keela Herr, Kenneth M Prkachin, et al.BMC Medical Education|April 29, 2016
Predictors of medical school clerkship performance: a multispecialty longitudinal analysis of standardized examination scores and clinical assessmentsPetra M Casey, Brian A Palmer, Geoffrey B Thompson, et al.Archives of Neurology|August 10, 2011
N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresisJonathan H Smith, Radhika Dhamija, Brian D Moseley, et al.Neurology|September 29, 2022
Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of RecurrenceJuliana H VanderPluym, Kartik Mangipudi, Amir Abdallah Mbonde, et al.Cephalalgia : an International Journal of Headache|April 7, 2026
Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label studyJohn Rothrock, Umer Najib, Jessica Ailani, et al.Pageof 8